Charlson Comorbidity Index (CCI)

Why use it

Gold standard comorbidity index in clinical research and quality improvement. Widely used as a covariate in epidemiological studies and clinical trials. Guides prognosis discussions, surgical risk assessment, and oncology treatment planning. Required for case-mix adjustment in administrative databases.

About

The Charlson Comorbidity Index (CCI) quantifies comorbidity burden by assigning weighted points to 17 medical conditions. The index was originally developed to predict 1-year mortality in hospitalized patients and has since been validated for 10-year survival prediction and as a case-mix adjustment tool in clinical research. Age is optionally added to the index for the Age-Adjusted CCI (ACCI). The combined score predicts 10-year survival probability.

When to use

• Preoperative risk assessment
• Prognosis discussion with patients and families
• Research case-mix adjustment and stratification
• Cancer treatment planning and eligibility
• Anesthesia and surgical risk evaluation
• Health services research and quality reporting

Formula

Pearls & pitfalls

• Age-Adjusted CCI (ACCI) adds 1 point per decade above age 50 (≤49 = 0, 50–59 = +1, 60–69 = +2, etc.).
• The 10-year survival estimates come from the age-adjusted version (van Walraven et al., 2009).
• Metastatic solid tumor (+6) is the single highest weighted condition.
• CCI does NOT include BMI, frailty, or functional status — consider these separately.
• Some conditions (e.g., diabetes with end-organ damage) are mutually exclusive with milder versions — use the higher score only.
• Updated version by Quan et al. (2011) improved coding for administrative data; original Charlson is standard for clinical use.

Next steps

CCI 0: No significant comorbidity. CCI 1–2: Low comorbidity burden. CCI 3–4: Moderate burden. CCI ≥ 5: Severe comorbidity — 10-year survival < 50%.

Evidence

Charlson et al. (J Chronic Dis 1987) original derivation in 559 medical patients. Age-adjusted version validated by Charlson et al. (1994) and further by van Walraven et al. (Arch Intern Med 2009, n=14,125). Most widely used comorbidity index in medical literature (>20,000 citations).

References

1. Charlson ME et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. — link
2. van Walraven C et al. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626-633. — link